Or how Artificial Intelligence can help tackle neurodegeneration
In conjunction with increasingly advanced computational approaches, a wide spectrum of neurodegenerative disease models, data-driven or knowledge-driven, have been developed. We want to capture biomedical data to detect neurodegenerative diseases (like Alzheimer’s, Parkinson’s disease) 15-20 years before the symptoms show. AI powered diagnostics and therapies to offer a longer health span.
Products & services
We introduce early non-invasive diagnostics of neurodegenerative diseases among adults aged 45 and up by affordable and an AI powered mobile application using digital biomarkers. Deep Medicine adopts a people-centred approach helping to create technical solutions to fulfil the needs of both patients and doctors with one goal in mind, to contribute to a healthier and longer life span. The solutions we develop use real-world data as the backbone of our innovations. As the diagnostic potential of AI is huge, it could be of fundamental importance in assisting doctors in the diagnosis of a vast number of diseases. The current focus of Deep Medicine lies with neurodegenerative diseases, such as Alzheimer’s Disease (AD), Parkinson’s Disease (PD) and Multiple Sclerosis (MS)